ClinicalTrials.gg

Program

SCTB35

A development code. Also written as “SCTB35 injection”.

Its studies are mostly in Lymphoma, Follicular · Lupus Erythematosus, Systemic · Lymphoma, Non-Hodgkin, led by Sinocelltech Group.

Furthest: phase 3, since Apr 24, 20264 company-led studies, 4 open or runningNext primary completion: May 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sinocelltech Group44 open or runningphase 3since Apr 24, 2026Mar 12, 2024May 2027phase 2 · NCT06841042

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 12, 2024First study: phase 1 study in Lymphoma, Non-HodgkinFirst studyNCT06318884 · 76 planned · China
  2. Feb 11, 2025Phase 2 study in Lupus Erythematosus, SystemicNCT06841042 · 168 planned · China
  3. Apr 24, 20262 phase 3 studiesPhase 3 reachedNCT07562022, NCT07570823

Ahead

  1. May 2027Primary completion: phase 2 study in Lupus Erythematosus, SystemicNCT06841042
  2. Nov 2027Primary completion: phase 3 study in Dendritic Cell Sarcoma, InterdigitatingNCT07570823
  3. May 2028Primary completion: phase 3 study in Lymphoma, FollicularNCT07562022

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07570823Dendritic Cell Sarcoma, Interdigitating · China3RecruitingNov 2027101
NCT07562022Lymphoma, Follicular · China3RecruitingMay 202893
NCT06841042Lupus Erythematosus, Systemic · China2RecruitingMay 2027168
NCT06318884Lymphoma, Non-Hodgkin · China1Not yet recruitingOct 202676

How it is read

Names in the registry

  • “SCTB35 injection”, 4 entries

Codes read as this program: SCTB35.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
SCTB35 (Sinocelltech Group): development program | ClinicalTrials.gg